FrancophonIA/ELRC3.0 huggingface dataset:
English: Very common side effects (may affect more than 1 in 10 people): - feeling depressed, irritability, trouble falling asleep or staying asleep, feeling anxious or nervous, difficulty concentrating, mood swings, - headache, dizziness, tired feeling, shaking chills, fever, flu-like symptoms, virus infection, weakness, - difficult breathing, pharyngitis (sore throat), coughing, - stomach pain, vomiting, nausea, diarrhoea, loss of appetite, loss of weight, dry mouth, - hair loss, itching, dry skin, rash, irritation or redness (and rarely, skin damage) at the site of injection, - decreases in the number of red blood cells (that may cause fatigue, shortness of breath, dizziness), decrease in certain white blood cells (that makes you more susceptible to different infections),
Slovenian: Zelo pogosti (pojavijo se lahko pri več kot 1 od 10 bolnikov): - depresija, razdražljivost, težave z uspavanjem ali zbujanje, tesnoba ali živčnost, težave s koncentracijo, nihanje razpoloženja, - glavobol, omotica, občutek utrujenosti, mrzlica s tresenjem, zvišana telesna temperatura, gripi podobni simptomi, virusna okužba, šibkost, - oteženo dihanje, faringitis (vneto grlo), kašelj, - bolečine v želodcu, bruhanje, siljenje na bruhanje, driska, izguba apetita, hujšanje, suha usta, - izpadanje las, srbenje, suha koža, izpuščaj, draženje ali pordelost (in redko poškodbe kože) na mestu injiciranja, - zmanjšanje števila rdečih krvnih celic (ki lahko povzroči utrujenost, kratko sapo, omotico),
English: From pre-treatment to end of long-term followup among subjects treated for 24 or 48 weeks, height-for-age percentiles decreased 1.3 and 9.0 percentiles, respectively.
Slovenian: Preiskovancem, zdravljenim 24 tednov, se je percentil telesne višine za starost od časa pred zdravljenjem do konca dolgoročnega spremljanja zmanjšal za 1,3 percentila, zdravljenim 48 tednov pa za 9,0 percentilov.
English: Reminder: Please read the “Pregnancy and breast-feeding” section of the Package Leaflet for ribavirin before using it in combination with this medicine.
Slovenian: Opozorilo: Prosimo preberite poglavje "Nosečnost in dojenje" v navodilu za uporabo ribavirina, preden ga začnete uporabljati v kombinaciji s tem zdravilom.
English: Careful co-administration of theophylline with the product (ViraferonPeg) is recommended.
Slovenian: Pri sočasni uporabi teofilina z zdravilom ViraferonPeg je potrebna previdnost.
English: Pulmonary infiltrates, pneumonitis, and pneumonia, occasionally resulting in fatality, have been observed rarely in interferon alpha treated patients.
Slovenian: V redkih primerih so pri bolnikih, zdravljenih z interferonom alfa, opažali pljučne infiltrate, pneumonitis in pljučnico, ki se občasno končajo s smrtjo.
English: 11 months) + ribavirin (1,000/1,200 mg/day), (n = 514).
Slovenian: 11 mesecev) + ribavirin (1.000/1.200 mg/dan) (n = 514) - Interferon alfa-2b (3 mio i.e. 3-krat na teden) + ribavirin (1.000/1.200 mg/dan) (n = 505)
English: Amount of ViraferonPe g to administer (µg)
Slovenian: Količina zdravila ViraferonP eg za uporabo (µg)
English: Reminder: Please read the “Warnings and precautions” section of the Package Leaflet for ribavirin before using it in combination with this medicine.
Slovenian: Opozorilo: Prosimo, preberite poglavje "Opozorila in previdnostni ukrepi" v navodilu za uporabo ribavirina, preden ga začnete uporabljati v kombinaciji s tem zdravilom.
English: Please refer to the ribavirin SmPC when ViraferonPeg is to be used in combination with ribavirin.
Slovenian: V primeru uporabe zdravila ViraferonPeg v kombinaciji z ribavirinom, prosimo, glejte SmPC za ribavirin.
English: • Platelets
Slovenian: • Trombociti
English: Reminder: Please read the “Other medicines” section of the Package Leaflet for ribavirin before using it in combination with this medicine.
Slovenian: Opozorilo: Prosimo, preberite poglavje "Druga zdravila" v navodilu za uporabo ribavirina, preden ga začnete uporabljati v kombinaciji s tem zdravilom.
English: Hydration
Slovenian: Hidracija
English: st dose reduction of ViraferonPeg is to 40 g/m 2/week, 2
Slovenian: Začetni odmerek 60 g/m2/teden zmanjšate na 40 g/m2/teden in nato na
English: 4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs
Slovenian: 4 viale praška, 4 ampule vehikla, 4 injekcijske brizge, 8 injekcijskih igel, 4 čistilni tamponi 6 vial praška, 6 ampul vehikla
English: Uncommon side effects (may affect up to 1 in 100 people): - painful or difficult urination, urinary frequency, the presence of excess protein in the urine, painful menstruation, - itchy anal area (pinworms or ascarids), inflammation of the lining membrane of the stomach and the intestines, inflamed gums, enlarged liver, - abnormal behaviour, emotional disorder, fear, nightmare, tremor, decreased sensitivity to touch, numbness or tingling feeling, pain radiating along the course of one or more nerves, drowsiness, - bleeding of the mucous membrane that lines the inner surface of the eyelids, itchy eyes, eye pain, blurred vision, intolerance to light, - low blood pressure, paleness, nasal discomfort, runny nose, wheezing, difficult breathing, chest pain or discomfort, - redness, swelling, pain of skin, shingles, skin sensitive to sunlight, rash with raised spotted lesions, skin discolouration, peeling of skin, shortening of muscle tissue, muscle twitching, facial pain, bruising.
Slovenian: Občasni (pojavijo se lahko pri največ 1 od 100 bolnikov): - bolečine ali težave pri uriniranju, pogosto uriniranje, prisotnost čezmerne količine beljakovin v urinu, boleče menstruacije, - srbenje v predelu zadnjika (podančice ali askaride), vnetje želodčne in črevesne sluznice, vnetje dlesni, povečana jetra, - nenormalno vedenje, čustvene motnje, strah, nočne more, tresenje, zmanjšana občutljivost na dotik, občutek odrevenelosti ali mravljincev, bolečina, ki seva vzdolž poteka enega ali več živcev, zaspanost, - krvavitev iz sluznice, ki pokriva notranjo površino očesnih vek, srbenje oči, očesne bolečine, zamegljen vid, neprenašanje svetlobe, - nizek krvni tlak, bledica, neugodje v nosu, izcedek iz nosu, piskanje v pljučih, težave z dihanjem, bolečine ali neugodje v prsih, - pordelost, otekanje, bolečine po koži, pasasti izpuščaj, občutljivost kože na sončno svetlobo, izpuščaj s privzdignjenimi pikčastimi spremembami, obarvanje kože, luščenje kože, skrajšanje mišičnega tkiva, trzanje mišic, obrazne bolečine, podplutbe.
English: The development of auto-antibodies and autoimmune disorders has been reported during treatment with alpha interferons.
Slovenian: Pri zdravljenju z alfa interferoni so poročali o pojavu avtoprotiteles in avtoimunih bolezni.
English: Powder: disodium phosphate; anhydrous, sodium dihydrogen phosphate dihydrate; sucrose and polysorbate 80.
Slovenian: Pomožne snovi: natrijev fosfat, brezvodni; natrijev dihidrogen fosfat dihidrat, saharoza in polisorbat 80.
English: Both the Metavir score and Ishak grade decreased among subjects treated with ViraferonPeg in combination with ribavirin.
Slovenian: Pri preiskovancih, zdravljenih z zdravilom ViraferonPeg v kombinaciji z ribavirinom, sta se zmanjšali tako ocena po Metavirju kot ocena po Ishaku.
English: SC
Slovenian: SN:
English: Baseline Viral Load
Slovenian: Uporaba pri ledvični okvari
English: Volume of ViraferonPeg to administer (ml)
Slovenian: Volumen zdravila ViraferonPeg za injiciranje (ml)
English: Tell your doctor or healthcare professional or the doctor or healthcare professional of the child you are caring for as soon as possible.
Slovenian: Če ste uporabili večji odmerek zdravila ViraferonPeg, kot bi smeli Čimprej povejte zdravniku ali zdravstvenemu delavcu ali zdravniku ali zdravstvenemu delavcu otroka, za katerega skrbite.
English: ViraferonPeg 150 micrograms - vial of powder
Slovenian: ViraferonPeg 150 mikrogramov - viala praška
English: Arthritis, back pain, muscle spasms, pain in extremity
Slovenian: artritis, bolečine v hrbtu, mišični krči, bolečine v udih
English: This leaflet was last revised in MM/YYYY
Slovenian: Navodilo je bilo nazadnje revidirano dne
English: ViraferonPeg 80 micrograms powder and solvent for solution for injection EU/1/00/132/006
Slovenian: ViraferonPeg 80 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/132/006
English: "Push-On Needle"
Slovenian: "Igla na potisk"
English: *, injection site inflammation, fatigue, asthenia, irritability, chills, pyrexia, influenza like illness, pain
Slovenian: *, vnetje na mestu injiciranja, utrujenost, astenija, razdražljivost, mrzlica, zvišana telesna temperatura, gripi podobna bolezen, bolečina
English: ViraferonPeg 150 micrograms powder and solvent for solution for injection EU/1/00/132/021
Slovenian: ViraferonPeg 150 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/132/021
English: ViraferonPeg 120 micrograms powder and solvent for solution for injection EU/1/00/132/016
Slovenian: ViraferonPeg 120 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/132/016
English: 15 SEC
Slovenian: 15 sekund
English: 1.5 mcg/kg/week (4 weeks)
Slovenian: 1,5 mcg/kg/ teden (4 tedne)
English: ViraferonPeg 80 micrograms - vial of powder
Slovenian: ViraferonPeg 80 mikrogramov - viala praška
English: Aplasia pure red cell Immune system disorders Uncommon:
Slovenian: čista aplazija eritrocitov Bolezni imunskega sistema Občasni:
English: A complete set of instructions is provided in the Annex to the Package Leaflet.
Slovenian: V dodatku k Navodilu za uporabo so podana podrobna navodila.
English: ViraferonPeg 120 micrograms - vial of powder
Slovenian: ViraferonPeg 120 mikrogramov - viala praška
English: The following treatment-related adverse reactions were reported in adults in clinical trials or through post-marketing surveillance in patients treated with peginterferon alfa-2b, including ViraferonPeg monotherapy or ViraferonPeg/ribavirin.
Slovenian: Med zdravljenjem so v času kliničnih preizkušanj ali v obdobju spremljanja zdravila na trgu pri odraslih bolnikih zdravljenih s peginterferonom alfa-2b, vključno z monoterapijo z zdravilom ViraferonPeg ali s kombinirano terapijo z zdravilom ViraferonPeg in ribavirinom poročali o naslednjih neželenih učinkih, povezanih z zdravljenjem.
English: Injection site erythema, fatigue, pyrexia, rigors, influenza-like illness, asthenia, pain, malaise, irritability
Slovenian: eritem na mestu injiciranja, utrujenost, zvišana telesna temperatura, okorelost, gripi podobna bolezen, astenija, bolečine, bolehnost, razdražljivost
English: Volume of ViraferonPe g to administer (ml)
Slovenian: Volumen zdravila ViraferonPe g za uporabo (ml)
English: Total daily ribavirin dose (mg)
Slovenian: Skupni dnevni odmerek ribavirina (mg)
English: ViraferonPeg 100 micrograms powder and solvent for solution for injection EU/1/00/132/011
Slovenian: ViraferonPeg 100 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/132/011
English: Powder: disodium phosphate, anhydrous; sodium dihydrogen phosphate dihydrate; sucrose and polysorbate 80.
Slovenian: Prašek: natrijev hidrogenfosfat, brezvodni; natrijev dihidrogenfosfat dihidrat, saharoza in polisorbat 80
English: ViraferonPeg 50 micrograms powder and solvent for solution for injection EU/1/00/132/001
Slovenian: ViraferonPeg 50 mikrogramov prašek in vehikel za raztopino za injiciranje EU/1/00/132/001
English: • Remove the pre-filled pen from the carton.
Slovenian: • Napolnjeni injekcijski peresnik vzemite iz škatle.
English: ViraferonPeg 50 micrograms - vial of powder
Slovenian: ViraferonPeg 50 mikrogramov - viala praška
English: Pulmonary fibrosis, pulmonary arterial hypertension Gastrointestinal disorders Very common:
Slovenian: pljučna fibroza, pljučna arterijska hipertenzija
English: Amenorrhoea, breast pain, menorrhagia, menstrual disorder, ovarian disorder, vaginal disorder, sexual dysfunction, prostatitis, erectile dysfunction
Slovenian: amenoreja, bolečine v dojkah, menoragija, menstrualne motnje, bolezni jajčnikov, bolezni vagine, spolne motnje, prostatitis, motnje erekcije Splošne težave in spremembe na mestu aplikacije Zelo pogosti:
English: ViraferonPeg is injected subcutaneously after reconstituting the powder as instructed, attaching a needle and setting the prescribed dose.
Slovenian: Po rekonstituciji praška v skladu z navodili, postavitvi igle na peresnik in nastavitvi predpisanega odmerka se zdravilo ViraferonPeg injicira subkutano.
English: ViraferonPeg 50 micrograms powder and solvent for solution for injection in pre-filled pen ViraferonPeg 80 micrograms powder and solvent for solution for injection in pre-filled pen ViraferonPeg 100 micrograms powder and solvent for solution for injection in pre-filled pen ViraferonPeg 120 micrograms powder and solvent for solution for injection in pre-filled pen ViraferonPeg 150 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b
Slovenian: ViraferonPeg 50 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku ViraferonPeg 80 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku ViraferonPeg 100 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku ViraferonPeg 120 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku ViraferonPeg 150 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku peginterferon alfa-2b
English: ViraferonPeg 100 micrograms - vial of powder
Slovenian: ViraferonPeg 100 mikrogramov - viala praška
English: Dental and periodontal disorders, which may lead to loss of teeth, have been reported in patients receiving ViraferonPeg and ribavirin combination therapy.
Slovenian: Pri bolnikih, ki so prejemali zdravilo ViraferonPeg z ribavirinom v kombinirani terapiji, so poročali o boleznih zob in obzobnega tkiva, ki lahko vodijo do izgube zob.
English: The reconstituted solution has a concentration of 120 micrograms/0.5 ml.
Slovenian: Koncentracija rekonstituirane raztopine je 120 mikrogramov/0,5 ml.
English: Haemoglobin
Slovenian: Hemoglobin
English: How to store ViraferonPeg
Slovenian: Shranjevanje zdravila ViraferonPeg
English: ViraferonPe g strength (g/0.5 ml)
Slovenian: Jakost zdravila ViraferonPe g (µg/0,5 ml)
English: The following treatment-related adverse reactions were reported in the study in children and adolescent patients treated with ViraferonPeg in combination with ribavirin.
Slovenian: V študiji pri otrocih in mladostnikih, zdravljenih z zdravilom ViraferonPeg v kombinaciji z ribavirinom, so poročali o naslednjih z zdravljenjem povezanih neželenih učinkih.
English: ViraferonPeg 50 micrograms powder and solvent for solution for injection ViraferonPeg 80 micrograms powder and solvent for solution for injection ViraferonPeg 100 micrograms powder and solvent for solution for injection ViraferonPeg 120 micrograms powder and solvent for solution for injection ViraferonPeg 150 micrograms powder and solvent for solution for injection peginterferon alfa-2b
Slovenian: ViraferonPeg 50 mikrogramov prašek in vehikel za raztopino za injiciranje ViraferonPeg 80 mikrogramov prašek in vehikel za raztopino za injiciranje ViraferonPeg 100 mikrogramov prašek in vehikel za raztopino za injiciranje ViraferonPeg 120 mikrogramov prašek in vehikel za raztopino za injiciranje ViraferonPeg 150 mikrogramov prašek in vehikel za raztopino za injiciranje peginterferon alfa-2b
English: Autoimmune disease
Slovenian: Avtoimune bolezni
English: Avoid your belly button (navel) and waistline.
Slovenian: Izognite se popku in predelu okrog pasu.
English: ViraferonPeg 50 micrograms powder and solvent for solution for injection ViraferonPeg 80 micrograms powder and solvent for solution for injection ViraferonPeg 100 micrograms powder and solvent for solution for injection ViraferonPeg 120 micrograms powder and solvent for solution for injection ViraferonPeg 150 micrograms powder and solvent for solution for injection
Slovenian: ViraferonPeg 50 mikrogramov prašek in vehikel za raztopino za injiciranje ViraferonPeg 80 mikrogramov prašek in vehikel za raztopino za injiciranje ViraferonPeg 100 mikrogramov prašek in vehikel za raztopino za injiciranje ViraferonPeg 120 mikrogramov prašek in vehikel za raztopino za injiciranje ViraferonPeg 150 mikrogramov prašek in vehikel za raztopino za injiciranje
English: You or your partner must use an effective birth control during the time you are taking ribavirin and for 7 months after stopping treatment.
Slovenian: V času jemanja ribavirina in še 7 mesecev po zaključku zdravljenja morate vi ali vaša partnerka uporabljati učinkovito kontracepcijo.
English: The reconstituted solution has a concentration of 150 micrograms/0.5 ml.
Slovenian: Koncentracija rekonstituirane raztopine je 150 mikrogramov/0,5 ml.
English: The reconstituted solution has a concentration of 120 micrograms in 0.5 ml.
Slovenian: Koncentracija rekonstituirane raztopine je 120 mikrogramov na 0,5 ml.
English: The reconstituted solution has a concentration of 80 micrograms/0.5 ml.
Slovenian: Koncentracija rekonstituirane raztopine je 80 mikrogramov/0,5 ml.
English: Liver enzymes and hepatic function should be closely monitored in cirrhotic patients.
Slovenian: Pri bolnikih s cirozo morate natančno spremljati jetrne encime in delovanje jeter.
English: One vial of powder contains 80 micrograms of peginterferon alfa-2b and provides 80 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Slovenian: Ena viala praška vsebuje 80 mikrogramov peginterferona alfa-2b in ima 80 mikrogramov/0,5 ml peginterferona alfa-2b po rekonstituciji v skladu s priporočili.
English: ViraferonPeg is supplied as: - 1 vial of powder for solution for injection and 1 ampoule of solvent for parenteral use; - 1 vial of powder for solution for injection, 1 ampoule of solvent for parenteral use, 1 injection syringe, 2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for parenteral use;
Slovenian: ViraferonPeg je na voljo v naslednjih pakiranjih: - 1 viala s praškom za raztopino za injiciranje in 1 ampula z vehiklom za parenteralno uporabo, - 1 viala s praškom za raztopino za injiciranje, 1 ampula z vehiklom za parenteralno uporabo, 1 injekcijska brizga, 2 injekcijski igli in 1 čistilni tampon, - 4 viale s praškom za raztopino za injiciranje in 4 ampule z vehiklom za parenteralno uporabo, - 4 viale s praškom za raztopino za injiciranje, 4 ampule z vehiklom za parenteralno uporabo, 4 injekcijske brizge, 8 injekcijskih igel in 4 čistilni tamponi, - 6 vial s praškom za raztopino za injiciranje in 6 ampul z vehiklom za parenteralno uporabo, - 12 vial s praškom za raztopino za injiciranje, 12 ampul z vehiklom za parenteralno uporabo, 12 injekcijskih brizg, 24 injekcijskih igel in 12 čistilnih tamponov.
English: The reconstituted solution has a concentration of 150 micrograms in 0.5 ml.
Slovenian: Koncentracija rekonstituirane raztopine je 150 mikrogramov na 0,5 ml.
English: What ViraferonPeg contains
Slovenian: Kaj vsebuje zdravilo ViraferonPeg
English: Disodium phosphate, anhydrous Sodium dihydrogen phosphate dihydrate Sucrose
Slovenian: Prašek natrijev hidrogenfosfat, brezvodni natrijev dihidrogenfosfat dihidrat saharoza polisorbat 80
English: The reconstituted solution has a concentration of 80 micrograms in 0.5 ml.
Slovenian: Koncentracija rekonstituirane raztopine je 80 mikrogramov na 0,5 ml.
English: Minimum delivery for pen is 0.2 ml.
Slovenian: Minimalni volumen za injiciranje pri peresniku je 0,2 ml. * Obvezna uporaba viale.
English: EU/1/00/132/008 (4 vials of powder, 4 ampoules of solvent) EU/1/00/132/009 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
Slovenian: EU/1/00/132/008 (4 viale praška, 4 ampule vehikla) EU/1/00/132/009 (4 viale praška, 4 ampule vehikla, 4 injekcijske brizge, 8 injekcijskih igel, 4 čistilni tamponi)
English: The plasma half-life of ViraferonPeg is prolonged compared with nonpegylated interferon alfa-2b.
Slovenian: V primerjavi z nepegiliranim interferonom alfa-2b je njegova razpolovna doba v plazmi daljša.
English: One vial of powder contains 120 micrograms of peginterferon alfa-2b and provides 120 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Slovenian: Ena viala praška vsebuje 120 mikrogramov peginterferona alfa-2b in ima 120 mikrogramov/0,5 ml peginterferona alfa-2b po rekonstituciji v skladu s priporočili.
English: ViraferonPeg 80 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
Slovenian: ViraferonPeg 80 mikrogramov prašek in vehikel za raztopino za injiciranje Eno vialo se rekonstituira z 0,7 ml vode za injekcije za dajanje do 0,5 ml raztopine.
English: The reconstituted solution has a concentration of 100 micrograms/0.5 ml.
Slovenian: Koncentracija rekonstituirane raztopine je 100 mikrogramov/0,5 ml.
English: nd dose reduction of ribavirin is to 8 mg/kg/day.
Slovenian: Pri otrocih in mladostnikih je prvo zmanjšanje odmerka ribavirina na 12 mg/kg/dan, drugo zmanjšanje odmerka ribavirina pa na 8 mg/kg/dan.
English: Also see SmPCs for ribavirin and boceprevir if ViraferonPeg is to be administered in combination therapy in patients with chronic hepatitis C.
Slovenian: Pri uporabi zdravila ViraferonPeg v kombinirani terapiji pri bolnikih s kroničnim hepatitisom C glejte tudi SmPC za ribavirin in boceprevir.
English: Pen label - ViraferonPeg 150 micrograms powder and solvent for solution for injection in prefilled pen
Slovenian: Nalepka na peresniku - ViraferonPeg 150 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
English: Desipramine (CYP2D6 substrate)
Slovenian: navedba smiselno ni potrebna dezipramin (substrat CYP2D6)
English: 12 vials of powder, 12 ampoules of solvent, 12 injection syringes, 24 injection needles and 12 cleansing swabs
Slovenian: 12 vial praška, 12 ampul vehikla, 12 injekcijskih brizg, 24 injekcijskih igel, 12 čistilnih tamponov 100 mikrogramov/0,5 ml
English: Pen label - ViraferonPeg 120 micrograms powder and solvent for solution for injection in prefilled pen
Slovenian: Nalepka na peresniku - ViraferonPeg 120 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku
English: Common side effects (may affect up to 1 in 10 people): - fungal infection, common cold, cold sores, pharyngitis (sore throat), sinusitis, ear infection, coughing, throat pain, feeling cold, eye pain, - decrease in blood clotting cells called platelets, that may result in easy bruising and spontaneous bleeding, swollen glands (swollen lymph nodes), blood thyroid tests abnormalities, decrease in thyroid gland activity, which may make you feel tired, depressed, increase your sensitivity to cold and other symptoms,
Slovenian: Pogosti (pojavijo se lahko pri največ 1 od 10 bolnikov): - glivične okužbe, navaden prehlad, herpesni izpuščaji, faringitis (vnetje grla), sinusitis, okužba ušes, kašelj, bolečine v grlu, občutek mrazenja, očesne bolečine, - zmanjšanje števila celic za strjevanje krvi, ki jim pravimo trombociti, kar lahko vodi do nagnjenosti k nastanku podplutb in spontanih krvavitev, otekle žleze (otekle bezgavke),
English: Headache, dizziness
Slovenian: glavobol, omotica
English: nd dose reduction of ViraferonPeg is to 0.5 µg/kg/week.
Slovenian: Če je potrebno, lahko še drugič zmanjšate odmerek zdravila ViraferonPeg, in sicer na 0,5 µg/kg/teden.
English: Weight decreased
Slovenian: Odpoved jeter
English: ViraferonPeg monotherapy - Adults
Slovenian: Monoterapija z zdravilom ViraferonPeg - odrasli bolniki Odmerek za injiciranje
English: Carton 50 micrograms powder and solvent for solution for injection in pre-filled pen
Slovenian: Škatla 50 mikrogramov prašek in vehikel za raztopino za injiciranje v napolnjenem injekcijskem peresniku